Trial intelligence / Profile preview

TAME using imipenem/cilastatin for chronic musculoskeletal pain

jRCTs061180011Completed

Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of imipenem + cilastatin in chronic musculoskeletal pain, adhesive capsulitis (AC), shoulder pain and 8 more. Primary endpoint: Pain intensity (Numerical Rating Scale). Started Nov 2017; status: completed.

02

Drugs

imipenem + cilastatin
03

Conditions

chronic musculoskeletal painadhesive capsulitis (AC)shoulder painTendinopathiesenthesiopathy

Beyond the preview

Go deeper on jRCTs061180011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061180011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call